Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-04 5:14 pm Purchase |
2023-04-03 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 697,511 12.600% |
424,928 (+155.89%) |
Filing History |
| 2023-03-06 4:07 pm Sale |
2022-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
DENNY GEORGE P III | 460,413 15.600% |
-4,447,579 (-90.62%) |
Filing History |
| 2023-01-31 4:05 pm Purchase |
2023-01-31 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 452,283 8.800% |
1,117 (+0.25%) |
Filing History |
| 2022-12-20 4:30 pm Sale |
2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 393,766 7.670% |
-1,701,234 (-81.20%) |
Filing History |
| 2022-12-14 4:30 pm Purchase |
2022-12-02 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 567,526 11.050% |
567,526 (New Position) |
Filing History |
| 2022-12-05 5:20 pm Sale |
2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 451,166 8.800% |
-4,296,079 (-90.50%) |
Filing History |
| 2022-12-02 5:01 pm Purchase |
2022-12-02 | 13G | Eterna Therapeutics Inc. ERNA |
Freebird Partners LP | 272,583 5.300% |
272,583 (New Position) |
Filing History |
| 2022-03-16 4:30 pm Sale |
2022-03-09 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 295,668 11.400% |
-19,997 (-6.33%) |
Filing History |
| 2022-02-16 5:15 pm Sale |
2021-12-31 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 104,750 4.000% |
-84,849 (-44.75%) |
Filing History |
| 2021-08-27 5:26 pm Purchase |
2021-08-27 | 13G | Eterna Therapeutics Inc. ERNA |
Factor Bioscience Inc. | 233,549 9.000% |
233,549 (New Position) |
Filing History |
| 2021-05-26 10:05 am Sale |
2021-05-25 | 13G | Eterna Therapeutics Inc. ERNA |
Custard & Pitts Investment Co. LP | 91,976 4.430% |
-12,500 (-11.96%) |
Filing History |
| 2021-05-24 1:03 pm Purchase |
2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA |
John D. Halpern | 237,362 11.400% |
237,362 (New Position) |
Filing History |
| 2021-05-18 11:48 am Purchase |
2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA |
Custard & Pitts Investment Co. LP | 104,476 5.030% |
104,476 (New Position) |
Filing History |
| 2021-05-13 5:00 pm Purchase |
2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA |
DENNY GEORGE P III | 245,400 11.800% |
245,400 (New Position) |
Filing History |
| 2021-05-13 5:00 pm Purchase |
2021-03-25 | 13D | Eterna Therapeutics Inc. ERNA |
Charles Cherington | 315,665 15.200% |
315,665 (New Position) |
Filing History |
| 2021-05-04 10:37 am Unchanged |
2021-05-03 | 13G | Eterna Therapeutics Inc. ERNA |
GENTILE GUY | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-04-30 4:05 pm Purchase |
2021-03-25 | 13G | Eterna Therapeutics Inc. ERNA |
Nicholas Jason Singer | 189,599 9.130% |
189,599 (New Position) |
Filing History |
| 2021-03-17 4:30 pm Sale |
2021-03-15 | 13D | NTN BUZZTIME, INC. NTN |
Hyperscale Data Inc. GPUS |
81,826 2.750% |
-111,230 (-57.62%) |
Filing History |
| 2021-03-16 4:30 pm Sale |
2021-03-12 | 13D | NTN BUZZTIME, INC. NTN |
Hyperscale Data Inc. GPUS |
193,056 6.490% |
-101,944 (-34.56%) |
Filing History |
| 2021-02-22 4:30 pm Unchanged |
2021-02-18 | 13D | NTN BUZZTIME, INC. NTN |
Hyperscale Data Inc. GPUS |
295,000 9.960% |
0 (Unchanged) |
Filing History |